Deng, R. et al. Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage harm in rat and canine osteoarthritis. Sci. Transl. Med. 16, eadh9751 (2024).
Zhou, D. et al. Intra-articular nanodrug supply methods for treating osteoarthritis. Drug Discov. Immediately 28, 103482 (2022).
Jones, I. A., Togashi, R., Wilson, M. L., Heckmann, N. & Vangsness, C. T. Jr Intra-articular remedy choices for knee osteoarthritis. Nat. Rev. Rheumatol. 15, 77–90 (2019).
Bedingfield, S. Ok. et al. Amelioration of post-traumatic osteoarthritis through nanoparticle depots delivering small interfering RNA to broken cartilage. Nat. Biomed. Eng. 5, 1069–1083 (2021).
James, S. L. et al. International, regional, and nationwide incidence, prevalence, and years lived with incapacity for 354 illnesses and accidents for 195 nations and territories, 1990–2017: a scientific evaluation for the International Burden of Illness Examine 2017. Lancet 392, 1789–1858 (2018).
Hunter, D. J., March, L. & Chew, M. Osteoarthritis in 2020 and past: a Lancet Fee. Lancet 396, 1711–1712 (2020).
Kim, H. et al. The present state of the osteoarthritis drug growth pipeline: a complete narrative overview of the current challenges and future alternatives. Ther. Adv. Musculoskel. 14, 1759720X221085952 (2022).
Lindström, E. et al. Nonclinical and medical pharmacological characterization of the potent and selective cathepsin Ok inhibitor MIV-711. J. Transl. Med. 16, 1–14 (2018).
Mancipe Castro, L., Garcia, A. & Guldberg, R. Biomaterial methods for improved intra-articular drug supply. J. Biomed. Mater. Res. A 109, 426–436 (2021).
Sterner, B. et al. The impact of polymer dimension and cost of molecules on permeation via synovial membrane and accumulation in hyaline articular cartilage. Eur. J. Pharm. Biopharm. 101, 126–136 (2016).
Rahimi, M., Charmi, G., Matyjaszewski, Ok., Banquy, X. & Pietrasik, J. Latest developments in pure and artificial polymeric drug supply techniques used for the remedy of osteoarthritis. Acta Biomater. 123, 31–50 (2021).
Rothenfluh, D., Bermudez, H., O’Neil, C. & Hubbell, J. Biofunctional polymer nanoparticles for intra-articular concentrating on and retention in cartilage. Nat. Mater. 7, 248–254 (2008).
Ji, M. et al. Exact concentrating on of miR-141/200c cluster in chondrocytes attenuates osteoarthritis growth. Ann. Rheum. Dis. 80, 356–366 (2020).
Chen, J. et al. A fast and modern pipeline for producing chondrocyte-homing peptide-modified extracellular vesicles by three-dimensional dynamic tradition of hADSCs spheroids to modulate the destiny of remaining ear chondrocytes within the M1 macrophage-infiltrated microenvironment. J. Nanobiotechnol. 22, 300 (2024).
Zhou, D. et al. MMP13-targeted siRNA-loaded micelles for analysis and remedy of posttraumatic osteoarthritis. Bioact. Mater. 37, 378–392 (2024).
Smith, A. E. & Helenius, A. How viruses enter animal cells. Sci. Adv. 304, 237–242 (2004).
Grove, J. & Marsh, M. The cell biology of receptor-mediated virus entry. J. Cell Biol. 195, 1071–1082 (2011).
Weissenhorn, W. et al. Structural foundation for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16, 3–9 (1999).
Von der Mark, Ok. et al. Sort X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum. 35, 806–811 (1992).
Knudson, W. & Loeser, R. CD44 and integrin matrix receptors take part in cartilage homeostasis. Cell. Mol. Life Sci. 59, 36–44 (2002).
Li, H., Wang, D., Yuan, Y. & Min, J. New insights on the MMP-13 regulatory community within the pathogenesis of early osteoarthritis. Arthritis Res. Ther. 19, 248 (2017).
Dissanayake, S., Denny, W. A., Gamage, S. & Sarojini, V. Latest developments in anticancer drug supply utilizing cell penetrating and tumor concentrating on peptides. J. Management. Launch 250, 62–76 (2017).
Olson, E. S. et al. Activatable cell penetrating peptides linked to nanoparticles as twin probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA 107, 4311–4316 (2010).
Jiang, T. et al. Tumor imaging by the use of proteolytic activation of cell-penetrating peptides. Proc. Natl Acad. Sci. USA 101, 17867–17872 (2004).
Zhang, H. et al. Sustaining hypoxia atmosphere of subchondral bone alleviates osteoarthritis development. Sci. Adv. 9, eabo7868 (2023).
Schipani, E. et al. Hypoxia in cartilage: HIF-1α is crucial for chondrocyte development arrest and survival. Genes Dev. 15, 2865–2876 (2001).
Kim, J.-w., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic change required for mobile adaptation to hypoxia. Cell Metab. 3, 177–185 (2006).
Stegen, S. et al. HIF-1α metabolically controls collagen synthesis and modification in chondrocytes. Nature 565, 511–515 (2019).
Bouaziz, W. et al. Interplay of HIF1alpha and beta-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage harm in mice. Proc. Natl Acad. Sci. USA 113, 5453–5458 (2016).
Ummarino, D. Hypoxia protects in opposition to cartilage loss by regulating Wnt signalling. Nat. Rev. Rheumatol. 12, 315–315 (2016).
Philip, M. et al. Metabolic research of hypoxia-inducible issue stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping management. Drug Check. Anal. 13, 794–816 (2021).
Stoddart, J. C., Dandridge, O., Garner, A., Cobb, J. & van Arkel, R. J. The compartmental distribution of knee osteoarthritis—a scientific overview and meta-analysis. Osteoarthr. Cartil. 29, 445–455 (2021).
Wang, Q. et al. Dysregulated integrin αVβ3 and CD47 signaling promotes joint irritation, cartilage breakdown, and development of osteoarthritis. JCI Perception 4, e128616 (2019).
Gao, J. et al. Overcoming limitations for intra-articular supply of disease-modifying osteoarthritis medication. Traits Pharmacol. Sci. 43, 171–187 (2022).
Shimomura, S. et al. Mechanical stimulation of chondrocytes regulates HIF-1α beneath hypoxic circumstances. Tissue Cell 71, 101574 (2021).
Adesida, A. B. et al. Human meniscus cells categorical hypoxia inducible factor-1α and elevated SOX9 in response to low oxygen pressure in cell mixture tradition. Arthritis Res. Ther. 9, R69 (2007).
Yu, Q. et al. Environment friendly siRNA switch to knockdown a placenta particular lncRNA utilizing RGD-modified nano-liposome: a brand new preeclampsia-like mouse mannequin. Int. J. Pharm. 546, 115–124 (2018).
Mao, X. et al. iRGD-conjugated DSPE-PEG2000 nanomicelles for focused supply of salinomycin for remedy of each liver most cancers cells and most cancers stem cells. Nanomedicine 10, 2677–2695 (2015).
Wei, Y. et al. Phospholipase A2 inhibitor-loaded micellar nanoparticles attenuate irritation and mitigate osteoarthritis development. Sci. Adv. 7, eabe6374 (2021).
Van den Borne, M. et al. Worldwide Cartilage Restore Society (ICRS) and Oswestry macroscopic cartilage analysis scores validated to be used in autologous chondrocyte implantation (ACI) and microfracture. Osteoarthr. Cartil. 15, 1397–1402 (2007).
Pritzker, Ok. P. et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr. Cartil. 14, 13–29 (2006).
Little, C. B. et al. The OARSI histopathology initiative—suggestions for histological assessments of osteoarthritis in sheep and goats. Osteoarthr. Cartil. 18, S80–S92 (2010).
Oláh, T. et al. Topographic modeling of early human osteoarthritis in sheep. Sci. Transl. Med. 11, eaax6775 (2019).